MedPath

Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning

Completed
Conditions
Covid19
Registration Number
NCT04855162
Lead Sponsor
Rush University Medical Center
Brief Summary

The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.

Detailed Description

Lung ultrasound (LUS) has recently gained popularity among the imaging methods to perform bedside assessment of critically ill patients to guide clinical management. LUS is a non-invasive and easy-to-perform procedure that provides precise data on lung aeration, lung recruitment, lung morphology, and lung perfusion. Studies have shown that LUS is a useful tool in monitoring lung reaeration in intubated patients diagnosed with traditional ARDS undergoing prone positioning; however there are mixed findings in terms of the use of LUS in predicting potential prone positioning response. A recent study found that the non-intubated COVID-19 patients who responded to prone positioning had more pronounced disturbances of aeration in posterior regions, however, they only investigated patients' response to the first prone positioning and the information for the patients' outcome is lacking. In our previous study with intubated COVID-19 patients, we found that patients' response to the subsequent prone positioning had higher predictive value than the response to the first prone positioning. Therefore, the primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  1. Adult subjects 18 years and older,
  2. Confirmed COVID-19 diagnosis
  3. Acute hypoxemic respiratory failure (SpO2/FiO2 or PaO2/FiO2 <300)
  4. Ordered self-prone positioning per medical team
Exclusion Criteria
  1. Pregnant
  2. Palliative care

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SpO2/FiO2 post prone in day 1post prone in day 1

Patients' response of oxygenation using SpO2/FiO2

SpO2/FiO2 pre prone in day 3Pre prone in day 3

Patients' response of oxygenation using SpO2/FiO2

Lung Ultrasound Score pre prone in day 1Pre prone in day 1

Patients' response of oxygenation using Lung ultrasound score

Lung Ultrasound Score post prone in day 3Post prone in day 3

Patients' response of oxygenation using Lung ultrasound score

SpO2/FiO2 pre prone in day 2Pre prone in day 2

Patients' response of oxygenation using SpO2/FiO2

SpO2/FiO2 post prone in day 2Post prone in day 2

Patients' response of oxygenation using SpO2/FiO2

SpO2/FiO2 post prone in day 3Post prone in day 3

Patients' response of oxygenation using SpO2/FiO2

SpO2/FiO2 pre prone in day 1pre prone in day 1

Patients' response of oxygenation using SpO2/FiO2

Lung Ultrasound Score post prone in day 2Post prone in day 2

Patients' response of oxygenation using Lung ultrasound score

Lung Ultrasound Score post prone in day 1Post prone in day 1

Patients' response of oxygenation using Lung ultrasound score

Lung Ultrasound Score pre prone in day 2Pre prone in day 2

Patients' response of oxygenation using Lung ultrasound score

Lung Ultrasound Score pre prone in day 3Pre prone in day 3

Patients' response of oxygenation using Lung ultrasound score

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Rush University Medical Center

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Hospital Civil Fray Antonio Alcalde

πŸ‡²πŸ‡½

Guadalajara, Jalisco, Mexico

Β© Copyright 2025. All Rights Reserved by MedPath